Nu-Med Plus NUMD
OTC NUMD
$0.01 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Nu-Med Plus (NUMD) Return on Equity [ROE] (2014 - 2021)

Updated

Nu-Med Plus' Return on Equity [ROE] came in at -495.05% for FY2021, up 3635.68 percentage points from -4130.73% in FY2020.

Analysis

Nu-Med Plus (NUMD) Return on Equity [ROE] (2014 - 2021) Analysis & Trends

  • Return on Equity [ROE] carries a three-year change of +1474.26 percentage points (FY2018 to FY2021).
  • Per Business Quant, earlier years put Return on Equity [ROE] at -4130.73% in FY2020 and -1969.31% in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 13.36%
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 10.39%
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 7.56%
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 17.60%
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 10.44%
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn -3.90%
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 14.31%
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 9.53%
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 3.88%
10 Nu-Med Plus 835,484.67 826,603.67 - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 -1,643.85%
Mar 31, 2021 -671.79%
Dec 31, 2020 -582.84%
Sep 30, 2020 -544.96%
Jun 30, 2020 -6,426.83%
Dec 31, 2018 -946.30%
Sep 30, 2018 -1,133.44%
Mar 31, 2018 -2,199.94%
Dec 31, 2017 -790.76%
Sep 30, 2016 -477.89%
Jun 30, 2016 -409.42%
Sep 30, 2014 -490.49%
Jun 30, 2014 -137.81%
Mar 31, 2014 -335.71%
API Access

Nu-Med Plus Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NUMD&period=max&api_key=YOUR_API_KEY